Citation Impact
Citing Papers
Excitatory amino acid antagonists for acute stroke
2003
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Management of Stroke in Infants and Children
2008
Suppression of Reactive Oxygen Species and Neurodegeneration by the PGC-1 Transcriptional Coactivators
2006 Standout
Glutamate receptors, neurotoxicity and neurodegeneration
2010
Halogen bonding: a general route in anion recognition and coordination
2010
Pre- and post-synaptic modulators of excitatory neurotransmission: comparative effects on hypoxia/hypoglycemia in cortical cultures
1994
Rasburicase (recombinant urate oxidase) for the management of hyperuricemia in patients with cancer
2003
Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation
2000 Standout
Different pathways for iNOS‐mediated toxicity in vitro dependent on neuronal maturation and NMDA receptor expression
2002
Glutamate spinal retrograde sensitization of primary sensory neurons associated with nociception
1994
Early Identification of Refractory Epilepsy
2000 Standout
Comparative study of voltage-sensitive sodium channel blockers in focal ischaemia and electric convulsions in rodents
1994
Spinal-cord injury
2002 Standout
The pyrimidine-derivative, BW1003C87, protects CA1 and striatal neurons following transient severe forebrain ischaemia in rats. A microdialysis and histological study
1993
Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals
2007 Standout
Nitric Oxide, Mitochondria, and Cell Death
2001
Cyclic guanosine 3′,5′-monophosphate-mediated neuroprotection by nitric oxide in dissociated cultures of rat dorsal root ganglion neurones
1997
Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy
1995
Examination of Several Potential Mechanisms for the Negative Outcome in a Clinical Stroke Trial of Enlimomab, a Murine Anti-Human Intercellular Adhesion Molecule-1 Antibody: A Bedside-to-Bench Study
2001
Triggering and execution of neuronal death in brain ischaemia: two phases of glutamate release by different mechanisms
1994
Food Deprivation Protects the Rat Striatum Against Hypoxia‐Ischemia Despite High Extracellular Glutamate
1994
The Science of Stroke: Mechanisms in Search of Treatments
2010 Standout
Uric Acid and Cardiovascular Risk
2008 Standout
Damage from oxygen and glucose deprivation in hippocampal slices is prevented by tetrodotoxin, lidocaine and phenytoin without blockade of action potentials
1994
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
Clinical trials for cytoprotection in stroke
2004
Initiation of Neuronal Damage by Complex I Deficiency and Oxidative Stress in Parkinson's Disease
2004
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Multiple sclerosis
2008 Standout
The neuroprotective agent riluzole inhibits release of glutamate and aspartate from slices of hippocampal area CA1
1993
Glutamate neurotoxicity and diseases of the nervous system
1988 Standout
Structure/activity relations of N-methyl-d-aspartate receptor ligands as studied by their inhibition of [3H]d2-amino-5-phosphonopentanoic acid binding in rat brain membranes
1988
The small GTP-binding protein Rab3A regulates a late step in synaptic vesicle fusion
1997 StandoutNatureNobel
The genetics of venous and arterial thromboembolism
2001
Novel Pharmacologic Strategies in the Treatment of Experimental Traumatic Brain Injury: 1998
1998
Graft-versus-host disease
2009 Standout
Genetic inactivation of adenosine A2A receptors attenuates acute traumatic brain injury in the mouse cortical impact model
2008
Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer?s disease
2004
Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity
2012 Standout
Prevention of Venous Thromboembolism
2004 Standout
The immunology of stroke: from mechanisms to translation
2011 Standout
Chapter 19 Role of endogenous nitric oxide and peroxynitrite formation in the survival and death of motor neurons in culture
1998
Neuroligin-1 Deletion Results in Impaired Spatial Memory and Increased Repetitive Behavior
2010 StandoutNobel
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
Persistent postsurgical pain: risk factors and prevention
2006 Standout
Calcium-related damage in ischemia
1996
Dose-ranging study of riluzole in amyotrophic lateral sclerosis
1996 Standout
NMDA Receptor Activation Increases Free Radical Production through Nitric Oxide and NOX2
2009
Inflammatory Neurodegeneration Mediated by Nitric Oxide, Glutamate, and Mitochondria
2003
The role of nitric oxide in multiple sclerosis
2002
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
2013 Standout
Biochemical and functional aspects on the control of prolactin release by the hypothalamo-pituitary GABAergic system
1989
Neuroprotective effects of lamotrigine in global ischemia in gerbils. A histological, in vivo microdialysis and behavioral study
1995
Nitric oxide, cell signaling and cell death
2005
Hippocampal slices: glutamate overflow and cellular damage from ischemia are reduced by sodium-channel blockade
1995
Transcranial Magnetic Stimulation: A Primer
2007 Standout
Ferroptosis: mechanisms, biology and role in disease
2021 Standout
Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
1994 Standout
BI-1 Regulates an Apoptosis Pathway Linked to Endoplasmic Reticulum Stress
2004 StandoutNobel
Carbon Monoxide and Nitric Oxide Suppress the Hypoxic Induction of Vascular Endothelial Growth Factor Gene via the 5′ Enhancer
1998 StandoutNobel
ERK Plays a Regulatory Role in Induction of LTP by Theta Frequency Stimulation and Its Modulation by β-Adrenergic Receptors
1999 StandoutNobel
Neuroprotective strategies for treatment of lesions produced by mitochondrial toxins: Implications for neurodegenerative diseases
1996
Mechanism of glutamate release from rat hippocampal slices during in vitro ischemia
1996
Lowering serum urate does not improve endothelial function in patients with type 2 diabetes
2007
Efficacy of lamotrigine in the management of chemotherapy‐induced peripheral neuropathy
2008
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
Voltage-Gated Sodium Channels and Hyperalgesia
2004
Intraischemic Hypothermia Decreases the Release of Glutamate in the Cores of Permanent Focal Cerebral Infarcts
1995
The functional anatomy of basal ganglia disorders
1989 Standout
Applications of the Morris water maze in the study of learning and memory
2001 Standout
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Regional Selective Neuronal Degeneration after Protein Phosphatase Inhibition in Hippocampal Slice Cultures: Evidence for a MAP Kinase-Dependent Mechanism
1998
The Free Radical Theory of Aging Matures
1998 Standout
Molecular mechanisms and therapeutic strategies related to nitric oxide
1995
Mechanisms of Deafferentation-Induced Plasticity in Human Motor Cortex
1998
Economic Burden of Chronic Lymphocytic Leukemia in the Era of Oral Targeted Therapies in the United States
2017
The Tumor Lysis Syndrome
2011 Standout
Efficacy and Safety of Rasburicase (recombinant urate oxidase) for the Prevention and Treatment of Hyperuricemia During Induction Chemotherapy of Aggressive Non-Hodgkin’s Lymphoma: Results of the GRAAL1 (Groupe d’Etude des Lymphomes de l’Adulte Trial on Rasburicase Activity in Adult Lymphoma) Study
2003
Cerebroprotective Effect of Lamotrigine After Focal Ischemia in Rats
1995
How mitochondria produce reactive oxygen species
2008 Standout
Ipilimumab plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid Malignancies
2017 StandoutNobel
XIV. International Union of Pharmacology Nomenclature in Nitric Oxide Research
1997 StandoutNobel
Changes in [3H]muscimol binding in substantia nigra, entopeduncular nucleus, globus pallidus, and thalamus after striatal lesions as demonstrated by quantitative receptor autoradiography
1983
Reversal of Experimental Parkinsonism by Lesions of the Subthalamic Nucleus
1990 StandoutScience
Results of alemtuzumab-based reduced-intensity allogeneic transplantation for chronic lymphocytic leukemia: a British Society of Blood and Marrow Transplantation Study
2005
Role of Central Nervous System-Derived or Circulating y-Aminobutyric Acid on Prolactin Secretion in the Rat
1981
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
Lamotrigine Protects Hippocampal CA1 Neurons From Ischemic Damage After Cardiac Arrest
1997
Ischemic Cell Death in Brain Neurons
1999 Standout
Quantification of risk factors for venous thromboembolism: a preliminary study for the development of a risk assessment tool.
2003
Cytosolic Ca2+Changes duringIn VitroIschemia in Rat Hippocampal Slices: Major Roles for Glutamate and Na+-Dependent Ca2+Release from Mitochondria
1999
Mucosal tolerance to E-selectin provides cell-mediated protection against ischemic brain injury
2003
The Halogen Bond
2016 Standout
Coagulation, inflammation, and apoptosis: different roles for protein S and the protein S–C4b binding protein complex
2003
Role of Adenosine 3′,5′-Monophosphate in the Effects of Insulin and Anti-insulin Serum on Liver Metabolism
1968 StandoutNobel
Deep Prepiriform Cortex Modulates Neuronal Cell Death in Global Ischemia
1997
The Chemistry behind Antioxidant Capacity Assays
2005 Standout
Nitric oxide prevents axonal degeneration by inducing HIF-1–dependent expression of erythropoietin
2011 StandoutNobel
ACCELERATED AGEING OR SELECTIVE NEURONAL LOSS AS AN IMPORTANT CAUSE OF DEMENTIA?
1979
Transport and Metabolism of Glutamate and Gaba in Neurons and Glial Cells
1981
CAR T cell immunotherapy for human cancer
2018 StandoutScience
STUDIES ON EXPERIMENTAL DIABETES. 3. EFFECTS OF ACUTE INSULIN INSUFFICIENCY ON 14C-GLUCOSE FORMATION FROM LABELED SUBSTRATES.
1964
Free Radicals in the Physiological Control of Cell Function
2002 Standout
Mechanisms and Effects of Intracellular Calcium Buffering on Neuronal Survival in Organotypic Hippocampal Cultures Exposed to Anoxia/Aglycemia or to Excitotoxins
1997
Excitatory amino acid release and free radical formation may cooperate in the genesis of ischemia-induced neuronal damage
1990
Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation
1983 StandoutScience
Nitric oxide and mitochondrial respiration
1999
Works of M.J. Leach being referenced
Population preference values for treatment outcomes in chronic lymphocytic leukaemia: a cross-sectional utility study
2010
Reduction of glutamate release and protection against ischemic brain damage by BW 1003C87
1992
Hippocampal NMDA/phencyclidine receptor binding sites are reduced following forebrain ischaemia in the gerbil
1988
The Sodium Channel Blocker and Glutamate Release Inhibitor BW1003C87 and Magnesium Attenuate Regional Cerebral Edema Following Experimental Brain Injury in the Rat
1995
Studies on the mechanism of action of the novel anticonvulsant lamotrigine (Lamictal) using primary neuroglial cultures from rat cortex
1993
Efficacy of urate oxidase (uricozyme) in tumour lysis induced urate nephropathy
1998
Neurochemical and Behavioral Aspects of Lamotrigine
1991
Uptake of l ‐2,4‐diamino [4‐3H]butyric acid into slices of rat cerebral cortex
1976
Long-term beneficial effects of BW619C89 on neurological deficit, cognitive deficit and brain damage after middle cerebral artery occlusion in the rat
1997
NEUROTRANSMITTER UPTAKE INTO SLICES OF RAT CEREBRAL CORTEX IN VITRO: EFFECT OF SLICE SIZE
1976
Vicious Cycle Involving Na+Channels, Glutamate Release, and NMDA Receptors Mediates Delayed Neurodegeneration through Nitric Oxide Formation
1996
Eradication of Minimal Residual Disease in B-Cell Chronic Lymphocytic Leukemia After Alemtuzumab Therapy Is Associated With Prolonged Survival
2005
Sipatrigine (BW 619C89) is a Neuroprotective Agent and a Sodium Channel and Calcium Channel Inhibitor
2000
Pharmacological Studies on Lamotrigine, A Novel Potential Antiepileptic Drug
1986 Standout
(±)-cis-2,3-piperidine dicarboxylic acid is a partial n-methy-d-aspartate agonist in the in vitro rat cerebellar cGMP model
1986
GABA receptor binding with 3H-muscimol in calf cerebellum
1978
Neuroprotective effects of a use-dependent blocker of voltage-dependent sodium channels, BW619C89, in rat middle cerebral artery occlusion.
1994
Genetic analysis, phenotypic diagnosis, and risk of venous thrombosis in families with inherited deficiencies of protein S
2000
BW619C89, a glutamate release inhibitor, protects against focal cerebral ischemic damage.
1993
Effect of ethanolamine-O-sulphate on regional gaba metabolism in the mouse brain
1977
Low Temperature X-ray Crystallographic Structures of Two Lamotrigine Analogues: (I) 2-Methyl,3-amino, 5-imino-6-(2,3-dichlorophenyl)-1,2,4-triazine Water Solvate and (II) 2-Methyl,3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine Isethionate, Hemi-hydrate
2008